Aster DM Q3 FY26: revenue up 13%, PAT hit by exceptional items

Exceptional ItemResults View source PDF Explain this filing

ASTERDM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹552.00

prior close

₹556.55

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.6%+3.1% vs market

Hospital peers, median of 21sector-0.6%+2.1% vs sector

On the reaction day the stock moved 3.1 pts more than Nifty Smallcap 250 and 2.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.8

10m

-3.3

15m

-2.2

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4-1.6+3.1-0.6+2.1

Next day

-1.3+1.3-2.6+0.6-2.0

-2.2+2.0-4.2+1.4-3.5

-2.8+1.0-3.8+0.6-3.4

+2.5+0.6+1.8-0.0+2.5

+3.7+3.2+0.5+3.5+0.2

+8.8+3.8+5.0+6.0+2.8

15d

+17.2+1.7+15.5+5.9+11.3

+17.6-1.2+18.7+3.6+14.0

+18.7-6.6+25.3-4.5+23.1

+34.2+7.2+27.1+7.3+26.9

UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aster DM Q3 FY26 consolidated revenue rose 13% YoY to Rs 1,185.76 crore (9M up 10% at Rs 3,460.84 crore). Q3 PAT dipped to Rs 58.65 crore from Rs 64.39 crore, weighed by Rs 28.29 crore exceptional items (mainly new Labour Code impact of about Rs 27.86 crore plus merger-related fees). Nine-month PAT still grew around 9% to Rs 273.52 crore. Standalone Q3 PAT rose 11% to Rs 55.16 crore on revenue of Rs 665.75 crore (up 16%). Board approved ESOP Scheme 2026, conversion of Rs 129.35 crore inter-corporate loan into equity of wholly owned subsidiary Aster DM Multispecialty Hospital, and a framework for group company loans, all pending shareholder approval via postal ballot.

Likely market impact

Revenue growth looks healthy; Q3 PAT dip is mostly a one-time Labour Code provision. Loan-to-equity conversion is neutral. ESOP and group loans await shareholder nod.